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Abstract Silver-staining methods are helpful for histo-
logical identiWcation of pathological deposits. In spite of
some ambiguities regarding their mechanism and interpre-
tation, they are widely used for histopathological diagnosis.
In this review, four major silver-staining methods, modiWed
Bielschowsky, Bodian, Gallyas (GAL) and Campbell–
Switzer (CS) methods, are outlined with respect to their
principles, basic protocols and interpretations, thereby pro-
viding neuropathologists, technicians and neuroscientists
with a common basis for comparing Wndings and identify-
ing the issues that still need to be clariWed. Some consider
“argyrophilia” to be a homogeneous phenomenon irrespec-
tive of the lesion and the method. Thus, they seek to explain
the diVerences among the methods by pointing to their
diVerent sensitivities in detecting lesions (quantitative
diVerence). Comparative studies, however, have demon-
strated that argyrophilia is heterogeneous and dependent
not only on the method but also on the lesion (qualitative
diVerence). Each staining method has its own lesion-depen-
dent speciWcity and, within this speciWcity, its own sensitiv-
ity. This “method- and lesion-dependent” nature of
argyrophilia enables operational sorting of disease-speciWc
lesions based on their silver-staining proWles, which may
potentially represent some disease-speciWc aspects. Fur-
thermore, comparisons between immunohistochemical and
biochemical data have revealed an empirical correlation
between GAL+/CS-deposits and 4-repeat (4R) tau (cortico-
basal degeneration, progressive supranuclear palsy and
argyrophilic grains) and its complementary reversal
between GAL-/CS+deposits and 3-repeat (3R) tau (Pick
bodies). Deposits containing both 3R and 4R tau (neuro-
Wbrillary tangles of Alzheimer type) are GAL+/CS+.
Although no molecular explanations, other than these
empiric correlations, are currently available, these distinc-
tive features, especially when combined with immunohisto-
chemistry, are useful because silver-staining methods and
immunoreactions are complementary to each other.
Keywords Argyrophilia · Gallyas · Campbell–Switzer · 
Tauopathies · Synucleinopathies · Senile plaques · 
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Introduction
The year 2006 was the centenary anniversary of the Wrst
clinical description of a presenile patient with progressive
cognitive decline, later deWned as Alzheimer’s disease
(AD) [7]. It was the same year (1906) when Santiago
Ramón y Cajal and Camillo Golgi were awarded the Nobel
prize for their contributions on neuroanatomy achieved by
using silver-staining methods, especially Golgi-silver tech-
nique. In the Weld of neuropathology as well, silver staining
was the principal method of choice at that time, which visu-
alized senile plaques (SPs), neuroWbrillary tangles (NFTs)
and Pick bodies [2]. More than 80 years have passed before
biochemical compositions of these pathological structures
were unveiled. During this period, technical trials to iden-
tify and localize these molecules on histological sections
showed the eVectiveness of immunohistochemistry and
revolutionized not only research but also routine diagnosis
in the Weld of neuropathology. Probably because of the
apparent success in the molecular explanation of diseases,
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recent attention to silver staining has not been very enthusi-
astic. Although most silver-staining methods are still left
with some ambiguities, neuropathologists have proWted by
their eYcacies. Silver-staining methods have been steadily
improved and one of the recent advances is undoubtedly
Gallyas method [41]. In practice, it allows stable, reproduc-
ible and sensitive visualization with low background. How-
ever, it is unfortunate that their principles, technical details
and interpretations, which are diVerent according to each
method, are sometimes not suYciently shared among neu-
ropathologists and technicians. It frequently happens that
some time-honored protocols are left without possible
explanations and their interpretation is often restricted to
“argyrophilic or not”. This naive interpretation is based on
the assumption that “argyrophilia” is a homogeneous phe-
nomenon irrespective of the staining method and the lesion.
Recent studies have demonstrated, on the contrary, that
“argyrophila” is heterogeneous and dependent on the stain-
ing method and the lesion [85, 119–122]. Here, established
silver-staining methods in the Weld of neuropathology are
reconsidered with the intension of improving their use and
interpretation.
The Wrst part of this review summarizes basic principles
and outlines protocols about four principal silver-staining
methods for formalin-Wxed, paraYn-embedded samples
from human autopsy brains mainly with degenerative dis-
eases, currently in use in our laboratory and their modiWca-
tions. Although other silver-staining methods have also
been invented to visualize normal neuronal structures,
astrocytes, microglia and experimental tissue samples, it is
not possible to encompass the whole range of these tech-
niques mainly because of the limitation of my own experi-
ence. The second part provides an overview of similarities
and diVerences between silver-staining methods and immu-
nohistochemistry, so that a comprehensive interpretation,
including their pitfalls results. Nevertheless, this review is
not intended to establish a relative grading of these methods
by identifying the possible superiority of a method (for
example, immunohistochemistry) over another (for exam-
ple, a silver-staining method). Instead, it is designed to
show how unique each staining method can be, by provid-
ing a distinct point of view, each independent of the other.
If we are prepared to take these possible diVerences of
staining methods into account, such an approach will pro-
vide a less biased, multi-faceted and fuller stereoscopic pic-
ture than can be achieved with immunohistochemistry
alone.
General principle of silver staining
The coloration in conventional histology is based on the
selective aYnity of a dye to some tissue elements relative to
surrounding elements and their permeability. This diVeren-
tial aYnity to speciWc tissue elements is Wnally represented
by the distinctive original color of the dye as seen with its
solution. This is essentially a single step procedure, called
dyeing, and does not involve chemical transformation of
the dye. Subsequent washing step is also selective in dis-
solving out the attached dye, which is called diVerentiation
[5]. Various combinations (for example, hematoxylin and
eosin, the Klüver-Barrera method, etc.) are currently in use
for neuropathological examinations. The mechanism of sil-
ver staining is, however, completely diVerent. Because the
solutions containing coloring agents used for silver-staining
methods are usually colorless, simple application of these
solutions to tissue sections, by itself, does not allow visual-
ization through light microscope even if the reagent has
some aYnity to the tissue elements. Subsequent chemical
transformation is necessary for visualization. In silver solu-
tions, most of the silver is present as ion or complex salt.
The silver ions should be Wrst attached to the target ele-
ments as silver ions or silver salts (step 1). This attachment,
however, does not allow visualization by itself. The
attached silver ions (Ag+) have to be reduced (=accept
electrons) to yield, in situ, metallic silver particles (Ag)
now visualized only if their amount and size are suYcient
for microscopic detection (step 2). Therefore, not only the
diVerential aYnity of the silver ion to some tissue elements
(step 1) but also its chemical transformation for visualiza-
tion (step 2) is essential. Although the attachment of silver
ions to tissue elements is based on the “in situ” formation
of silver salt, these silver ions, either in the solution or as
salts, are reducible. They undergo reduction to form metal-
lic silver. Gallyas demonstrated that there is a time lag
between the rapid attachment of silver ions onto the section
(step 1, within 15 min) and delayed formation of metallic
silver particles (step 2) there [42]. Because these two steps
are independently aVected by pH, temperature, the concen-
tration of silver ion and coexisting molecules [42], these
steps are independent even if both take place in a single
manipulation. This dual function of silver, that enables
“site-directed chemical transformation”, is fundamental to
various silver-staining methods.
Because some tissue elements (glutathione, creatine,
adrenaline etc.) exhibit an intrinsic reducing capacity,
which may be strong enough to reduce silver ions into
metallic silver particles in situ, these two steps (selective
attachment and visualization after reduction of silver ions)
may take place in a single manipulation. This is called sil-
ver reaction or “argentaYn” reaction [35, 102]. When the
reducing capacity of the tissue elements is absent or not
suYcient, it is necessary to provide reducing agents exter-
nally after silver ions have been attached to the tissue ele-
ments. It is also possible to facilitate or modify these steps
by some reagents [40]. Anyway, this two-step procedure isActa Neuropathol (2007) 113:483–499 485
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called postblackening (Nachschwärzen) or “argentophilic”
reaction [35, 102] and most of the current silver-staining
methods for neuropathology consist, in essence, of at least
these two steps. If suYcient amount of silver ions have
been attached to the tissue elements but not have been
reduced spontaneously after step 1, it is possible to visual-
ize them simply by applying an appropriate reducing agent
externally. This is called chemical development, during
which the amount of deposited silver in the tissue section
remains unchanged. However, it is not easy to increase the
amount of silver deposits during step 1. For example,
increasing the concentration of silver reagents or prolonga-
tion of incubation time is frequently hampered by non-
speciWc staining. This trade oV between sensitivity and
speciWcity, principally encountered in all kinds of staining,
is especially troublesome with silver-staining methods
because reactions in the silver solutions and those in reduc-
ing agents are both capricious and diYcult to standardize.
This is one of the reasons why more sensitive, stable and
reproducible silver solutions and staining methods have
been a matter of considerable endeavor for a long period, as
will be discussed later.
Particle size and possible determinants of selective 
staining
It has been reported that the apparent color of silver-stained
elements is correlated with the size of Wnal silver particles.
In the test tube, the smallest range in their diameter (10–
20 nm) is correlated with yellow color. The largest range
(>100 nm) is associated with black color. Intermediate
ranges are correlated with red (>30 nm) or blue-purple (50–
60 nm) [102,  103], as reported by Liesegang [70]. The
emission spectra of Xuorogenic semiconductor nanocrys-
tals, recently introduced for Xuorolabeling, are dependent
not only on their materials but also on their particle size
[20, 22]. Although the size range of semiconductor nano-
crystals (2–6 nm) is much smaller than that of silver parti-
cles, it is interesting to note that these diVerences in their
color spectra are dependent on the particle size in both sil-
ver particles and the nanocrystals. Others reported, how-
ever, that black color is correlated with a larger amount of
deposits [35]. Although the deposition of silver particles is
primed by an aYnity of the silver ion to some tissue ele-
ments, is this aYnity the only major determinant of the
selective staining? According to Seki [102], some colloidal
substance in the tissue may hinder formation and deposition
of metallic silver particles (Schutzkolloid). In addition,
packing density of tissue ultrastructures (for example, Wber
density) may also be responsible, because an excessive
looseness of the structure may not allow secure settlement
of silver particles. It is also possible that its extreme tight-
ness does not permit appropriate growth of silver particles.
He then concluded that a small quantity of this intervening
colloid (eine Armut an Schutzkolloid) and an appropriate
density of the structure (eine passende Strukturdichte) of
the target structure are also important for the selectivity of
silver staining. This idea that some spatial constraints
around silver particles, in addition to the primary aYnity of
the silver ion, are essential in determining the selectivity
of silver staining may be related to the current concept of
disease-speciWc “conformational status” of pathological
deposits and their constituent molecules.
These explanations are, however, far from complete for
the majority of silver-staining methods. Furthermore,
because these experiments have been performed mainly in
animal tissues, in which sampling and handling of tissue
materials are optimal, it remains to be clariWed whether
similar explanations are applicable to human samples
obtained for neuropathological examinations, often con-
taining distinct pathological lesions and suVering from sub-
optimal handling such as postmortem delay, suboptimal
Wxation and embedding in paraYn wax. Even though vari-
ous methods for celloidin- or paraYn-embedded autopsy
samples have been invented. Table 1 shows fundamental
steps and contents of the solutions for the silver-staining
methods currently in use in our laboratory.
Bielschowsky methods
Improvements in silver-staining methods have often been
derived from chemistry. The ammoniacal silver solution
had been used for production of mirror, based on the nature
of the complex “silver diamine [Ag(NH3)2]+ “ in the solu-
tion that is liable to precipitate, after being reduced, at the
interface between the glass surface and the solution. This is
called the silver mirror reaction and it was Fajersztajn who
initially applied this phenomenon to tissue staining [34].
Later, Max Bielschowsky [8] improved this method by
incubating formalin-Wxed frozen sections in the silver
nitrate prior to the ammoniacal silver solution (Table 1).
Although the exact mechanism still remains to be clariWed
[100], it is plausible that this prior treatment with the silver
nitrate provides active foci for subsequent silver deposition
in the ammoniacal silver solution [50]. Anyway, it is rea-
sonable to suppose that this stepwise impregnation (silver
nitrate-ammoniacal silver) improved the staining probably
by increasing the amount and the size of silver precipitates
[66]. Early modiWcations of Bielschowsky method were
summarized by Beech and Davenport [6]. Garven and
Gairns [50] provided a comprehensive review on the possible
mechanism of the so-called Bielschowsky-Gros method
and its modiWcations. The presence of a huge number of
modiWcations, however, indicates that this method is highly486 Acta Neuropathol (2007) 113:483–499
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unstable and still awaits improvements. A modiWcation for
paraYn-embedded samples of normal neural tissues from
various animal species was Wrst proposed by Sevier and
Munger [105]. Practically, it is probably Yamamoto–
Hirano’s modiWcation [131], which is currently accepted as
the standard Bielschowsky method for neuropathological
examination of paraYn-embedded autopsy samples (Table 1).
This Yamamoto–Hirano’s modiWcation is diVerent from
other conventional modiWcations of Bielschowsky method
because the usual silver nitrate–ammoniacal silver sequence
is followed by another ammoniacal silver solution containing
developers.
Bodian method
Bodian established a new method, applicable to paraYn-
embedded sections, for staining nerve Wbers and nerve end-
ings [9, 10]. This method is rather stable and reproducible
and is currently in use for neuropathology. He used 1% sil-
ver proteinate (which usually contains 8% of silver) solu-
tion and placed metallic copper in it. Because the staining
does not work well in the absence of metallic copper, he
speculated that metallic copper might regulate the deposi-
tion of metallic silver by decreasing the concentration of
silver ion [9, 10]. However, the mixture of silver nitrate and
powdered egg albumin was reportedly successful even in
the absence of metallic copper [92]. Nevertheless, the mea-
sured concentration of silver ion gradually decreases after
addition of metallic copper, as demonstrated by two inde-
pendent groups [64, 93]. Concomitant and gradual increase
in the concentration of copper ion [64, 93] is accompanied
by a decrease in pH [93]. These reciprocal changes between
concentrations of silver and copper ions are mainly
explained by a primary diVerence in ionization energy
between copper and silver. In other words, copper is more
liable to be ionized than silver. Because their concentra-
tions are not inXuenced by the presence of sections in the
solution, the amount of silver ion trapped in the section is
practically negligible. While the addition of metallic copper
up to 5 g/100 ml progressively decreases the concentration
of silver ion in dose-dependent fashion (from 1,000 to
250 g/ml), further increase in the amount of metallic cop-
per up to 15 g/100 ml does not lead to further increase in
the copper ion nor further decrease in the silver ion in the
solution [64]. Indeed, this amount of copper, 5 g/100 ml, is
in perfect agreement of the amount, 4–6 g/100 ml, origi-
nally recommended by Bodian [9, 10] and the amount of
metallic copper more or less than this range does not give
optimal results. Interestingly, not only the amount of metal-
lic copper but also the shape of metallic copper (foil, plate,
chip or granules) inXuences the concentration of copper and
silver ions and the results of staining. The metallic copper
as “foil” is correlated with the highest concentration of cop-
per ion and the most intense staining [64, 93]. Moreover,
these reactions in the silver proteinate solution occur slowly
and the equilibrium is reached after 12–16 h. Figure 1 illus-
trates putative chronological events during incubation in
the silver proteinate solution and development. In the early
phase of silver impregnation, the high concentration of
silver ion facilitates its attachment to the section (step 1,
Fig. 1). This initial attachment is apparently not selective,
because early interruption of incubation yields an overall
nonselective nerve staining [93]. Gradual deposition of sil-
ver ion as metallic silver on the surface of metallic copper
(step 2, Fig. 1) leads to a gradual decrease in the concentra-
tion of silver ion and a concomitant increase in the concen-
tration of copper ion in the solution. Continued incubation
in the solution with a decreasing concentration of silver ion
facilitates liberation of the silver ion, once trapped in the
section, back into the solution (step 3, Fig. 1). The selective
staining of Bodian method is explained if this rate of libera-
tion of silver ion back to the solution (step 3, Fig. 1) is
diVerent according to the tissue elements. This chronologi-
cal change may be necessary to yield the selective staining
and explains why an equivalent concentration of copper ion
provided as copper sulfate instead of metallic copper does
not yield similar results [64]. Some copper ions are also
deposited onto the section (step 4, Fig. 1). Residual silver
proteinate as colloidal fraction may release silver ions grad-
ually throughout the incubation (step 5, Fig. 1). For prac-
tice, (1) 5 g of metallic copper as foil in 100 ml of 1% silver
proteinate solution and (2) incubation for 16–24 h are rec-
ommended as optimal for Bodian method [64].
After being incubated in the silver proteinate solution,
sections are treated with 1% hydroquinone with 5% sodium
sulWte for reduction (step 6, Fig. 1) [9,  10]. It has been
reported that formaldehyde, suitable for reducing the silver
diamine of Bielschowsky method, is not appropriate by
itself for reducing the silver ions in Bodian method. In con-
trast, hydroquinone suitable to reduce the silver ions in
Bodian method is not appropriate for reducing the silver
diamine of Bielschowsky method [35]. However, some rec-
ommended formaldehyde in combination with hydroqui-
none for the reducing step of Bodian method [9,  10].
Because it is usually after the incubation in the developer
when the sections appear contrasted for visualization, it
seems reasonable to suppose that deposited silver ions are
reduced to form metallic silver only after exposure to
hydroquinone. If this is the case, treatment of the silver
impregnated sections with sodium sulWte, which dissolves
out silver salt but not metallic silver, will diminish the
staining. On the contrary, Peters [93] demonstrated the
presence of sodium sulWte-resistant metallic silver and sug-
gested that at least some fraction of silver ions have already
been reduced to metallic silver during incubation in the488 Acta Neuropathol (2007) 113:483–499
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silver proteinate solution (asterisk, step 4, Fig. 1). They may
serve as nuclei that attract surrounding reducible silver
ions/salts to form larger metallic silver particles during sub-
sequent development. Indeed, Gallyas demonstrated that
radiolabeled silver ions in the silver proteinate solution are
deposited to the section in the form of metallic silver even
before the development. This is based on the Wnding that
the radiolabeled silver on the section is resistant to the treat-
ment with 1% silver nitrate/10% acetic acid that washes out
reducible silver ions but not metallic silver particles.
Because the localization of this radiolabeled silver, now
deposited as metallic silver, is in good agreement with the
Wnal image of the adjacent section stained by Bodian
method, it is likely that these metallic silver deposits play a
determinant role in deWning  Wnal image obtained with
Bodian method [44]. At any rate, it is possible to intensify
the staining through subsequent gold toning by incubating
in 1% gold chloride with glacial acetic acid (three drops for
100 ml). Although the mechanism of Bodian method, espe-
cially that of copper ion, is not yet completely clariWed, not
only silver but also copper ions are retrieved in the gold
chloride solution for toning (double asterisk, step 7, Fig. 1)
[64]. This indicates that the ionized copper in the silver pro-
teinate solution has been deposited on the tissue and that
the deposited copper, in addition to silver, is replaced with
gold [64]. This dual replacement may explain why this gold
toning is necessary and particularly eVective for Bodian
method. After gold toning, it is now possible and necessary
to treat the sections with 5% sodium thiosulfate to dissolve
out silver ions that remain unreduced in the tissue. Other-
wise, these remaining ions may be reduced after exposure
to light to form undesirable precipitates. Because Bodian
method was originally invented to stain normal axons and
neuroWbrils, these normal structures are always superim-
posed on pathological structures such as SPs and NFTs.
These intervening normal structures are one of the major
hindrances of Bodian method especially when examining
silver-stainable deposits overlaid on normal structures.
Fig. 1 Mechanism of the Bodian method. Step 1: Attachment of silver
ions to the section driven by high concentration of silver ions; single
asterisk: a fraction of silver ions are already reduced to metallic silver
even before chemical development. Step 2: Deposition of silver ions as
metallic silver leads to a decrease in the concentration of silver ion and
reciprocal liberation of copper ions. Step 3: Delayed liberation of silver
ions from the section back to the solution with decreased concentration
of silver ion after step 2. Step 4: Copper ions are now available in the
solution after step 2 to be attached on the section. Step 5: Silver prote-
inate gradually releases silver ions during steps 1–4. Step 6: Not only
silver but also copper ions/salts on the section are reduced to metallic
particles. Step 7: These metallic particles are replaced with metallic
gold; double asterisk: retrieval of copper ions in the gold chloride solu-
tion indicates that metallic copper has been deposited on the section
(steps 4 and 6). Symbols: circle: silver; square: copper; pentagon:
gold; blank symbols: reducible (ion/salts); Wlled symbols: metallicActa Neuropathol (2007) 113:483–499 489
123
Gallyas method
Another way of improvement had been achieved based on
the chemical principle of photography, “physical develop-
ment”. As opposed to the chemical development, additional
silver ions are provided with reducing agents to form silver
particles around the reactive foci, which have been already
activated after exposure to light in dose-dependent manner.
This greatly increases the amount of metallic silver or oxi-
dized silver that are now visible as photographic images. It
was Liesegang who Wrst introduced this idea to histological
staining in an attempt to establish a more consistent and
reproducible method of silver staining [70, 88]. The proto-
cols with physical development were later customized suc-
cessfully for neuropathology by Gallyas [40]. Because
physical developer solutions contain, in general, silver ions
and reducing agents that together react rapidly, protecting
colloid (tungsto-silicic acid for Gallyas method) is included
in order to control by retarding this reaction [43].
As with other silver-staining methods, the attachment of
silver ion to speciWc targets determines Wnal localization of
silver particles. According to Gallyas, this speciWc attach-
ment is mediated by some determinant substance, which
binds to the target tissue elements or the tissue elements
themselves, followed by their chemical modiWcations.
These foci are enabled to attract silver ions to form silver
salts. Otherwise, the determinant substance renders these
foci capable of reducing silver ions to form submicroscopic
metallic silver particles bound to the target elements. The
chemical nature of the original determinant substance may
determine which components (for example, Wbrous astro-
cytes, microglia or oligodendrocytes) in the section are
Wnally silver-stained [37–39]. For visualization of NFTs,
sections are incubated with silver iodide in alkaline condi-
tion that exhibits aYnity to NFTs [41] (Table 1). Although
Gallyas customized protocols according to various target
structures other than NFTs [37–39], this silver iodide proto-
col for NFTs, currently in routine use for neuropathological
diagnosis, is deWned in this review as “Gallyas method” for
simplicity and convenience. If this silver solution is pre-
pared with radiolabeled silver, it is possible to quantify the
silver ions/particles after each step of the staining protocol.
Gallyas demonstrated that most of the silver attached to the
section after incubation in this silver iodide solution is
reducible silver salt but not metallic silver, because it is
washed out after incubation in nonlabeled 1% silver nitrate/
10% acetic acid (Table 1 of Ref. [44]), a treatment that
expels reducible silver ions/salts from the sections. Incuba-
tion in sodium thiosulfate or sodium cyanide, alternate
ways to expel these reducible silvers, diminishes the Wnal
image, again compatible with the assumption that the
attached silver after incubation in the silver iodide solution
is silver ions/salts but not metallic silver [41].
Is a separate step necessary to transform these attached
silver ions/salts into metallic silver particles so that they
may subsequently work as nuclei for subsequent growth of
silver particles in the physical developer? Because the
reducing agent in the physical developer is ready to reduce
these attached silver ions/salts into metallic silver nuclei, an
isolated step for reduction is not necessary before the treat-
ment in the physical developer. However, a brief exposure
of the silver-impregnated sections to formalin prior to the
physical development leads to an instantaneous completion
of the physical development [41]. However, it is possible
that silver ions contained in the physical developer poten-
tially attaches to the tissue and are physically developed to
form separate metallic silver particles. Because this may
happen independently of the silver from the initial alkaline
silver iodide solution [45], a prolonged incubation in the
physical developer may be hampered by this unexpected
staining. Therefore, pretreatments have been invented in
order to minimize this background. A pretreatment initially
proposed by Gallyas was 5% periodic acid for 30 min. He
tried various pretreatments [46] and Wnally proposed an
alternative pretreatment with 0.4% lanthanum nitrate/2%
sodium acetate in H2O2 for 1 h, which is more eVective in
eliminating the background [47]. An additional pretreat-
ment with sodium permanganate followed by oxalic acid
[114] (initially intended for melanin bleaching [71]) prior
to this lanthanum nitrate/sodium acetate treatment of Gall-
yas [47] was found highly eVective in eliminating the back-
ground and is currently in use as the standard in our
laboratory. The background staining is practically negligi-
ble because the expected target staining is usually obtained
before long and this untoward background reaction is gen-
erally slow. Similar oxidative pretreatments are not beneW-
cial for other silver-staining methods [68]. The subsequent
gold toning is essentially similar to that for Bodian method.
Compared with Bodian and Bielschowsky methods,
Gallyas method is characterized by its stability, reproduc-
ibility and ability to visualize abundant deposits [15].
Moreover, normal structures are not stained in practice.
This allows easy and reproducible examination especially
when looking for pathological deposits such as NFTs or
glial cytoplasmic inclusions (GCIs) of multiple system
atrophy (MSA) [90, 119]. However, amyloid deposits are
hardly visualized and it is usually neuritic components of
SPs that are labeled by Gallyas method.
Campbell–Switzer method
The initial impregnation solution of Campbell–Switzer
method contains pyridine (Table 1). Pyridine was initially
used for tissue Wxation. Bielschowsky [8] used pyridine for
postWxation of formaldehyde-Wxed frozen sections and490 Acta Neuropathol (2007) 113:483–499
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found an enhanced selectivity. In order to avoid instability
and risk of explosion of the ammoniacal silver solution,
Hicks [57] added pyridine (4.4 vol%) to the silver nitrate
solution (0.55%) buVered with potassium carbonate at alka-
line range. Thereafter, Campbell et al. [21] combined this
silver-pyridine (2.5 vol%)-carbonate solution with the
physical developer invented by Gallyas and found that this
staining is not only highly sensitive in detecting SPs and
NFTs in AD brains but also as stable and reproducible as
Gallyas method. The solution was later modiWed by
increasing the concentration of pyridine up to 8.7% [13]
and was found to be equally very powerful in detecting -
synuclein-related pathologies [101]. Gallyas demonstrated
that the presence of pyridine markedly decreases the
amount of silver, either metallic or reducible, attached to
the section [42]. This is compatible with the observation
that pyridine enhances the selectivity of Bielschowsky
method [8] and that a higher concentration of pyridine is
associated with reduced background [21]. Because the stan-
dard pretreatment (potassium permanganate/oxalic acid fol-
lowed by lanthanium nitrate) for Gallyas method does not
aVect the results obtained with Campbell–Switzer method
and there are essentially no diVerences between the physi-
cal developers used for Gallyas and Campbell–Switzer
methods, the only signiWcant diVerence between them is the
silver solutions [86]. The reason for these diVerences
between Gallyas and Campbell–Switzer methods remains
unexplained.
Enhancement of silver staining by methenamine
Methenamine has been used for histological demonstration
of glycogen and mucin [52]. Periodic acid-methenamine
silver stain has been used for staining of the basement
membrane of the glomeruli [61]. Dekura et al. [30]  Wrst
described the use of the methenamine-silver solution for
neuroWbrils without prior periodic acid. Further modiW-
cation of this methenamine-silver method was found
highly sensitive in detecting SPs, which is equivalent to
immunohistochemistry for amyloid -protein (A) [1, 53].
Interestingly, formic acid pretreatment, which enhances
immunoreactivity for A of SPs, completely diminishes
argyrophilia of SPs by the methenamine-silver method
or congophilia, suggesting that the methenamine-silver
method detects speciWc structures, such as -pleated sheets
of amyloid, which are destroyed by formic acid [130]. It
also stains perivascular amyloid but fails to stain Kuru
plaque of Gerstmann–Sträussler–Scheinker disease [130]
and renal deposits of amyloid [53]. This is in agreement
with the early speculation by Seki [102] that factors other
than direct aYnity of silver to some tissue elements, such as
the quantity of intervening colloid or packing density of
tissue components are also responsible for Wnal results of the
silver staining. The paucity of normal neuroWbrils with this
method is helpful in delineating SPs on electron micros-
copy [76]. It is then possible to detect even sparse aggrega-
tions of amorphous, often ramiWed structures with Wne
granular silver deposits, suggesting that this highly sensi-
tive method is capable of detecting the earliest stage of A
deposition [58]. Although the mechanism of lesion-speciWc
enhancement remains unknown, introduction of 5% of
methenamine in the silver proteinate solution of Bodian
method is similarly eVective in enhancing the selective
aYnity to SPs and NFTs [65]. It is interesting that this
methenamine-silver method exhibits more aYnity to Pick
bodies when they are extracellular [89], while intracellular
counterparts are more readily stained by conventional
Bodian method even with electron microscopy [91].
Pretreatment with microwave
A microwave treatment of sections in silver solution was
Wrst reported by Brinn [19]. This treatment causes an
increase in molecular movements across the tissue. This
presumably facilitates quicker silver impregnation. At the
same time, shortened incubation time for impregnation and
activated molecular movements may minimize precipitate
formation. Microwave activation of silver impregnation for
SPs and NFTs was Wrst introduced in order to apply King’s
method [63] (originally designed for frozen sections) to
paraYn-embedded sections [74]. Microwave activation is
eVective with Bielschowsky [23] and the methenamine
silver [36] methods in shortening the incubation time for
silver impregnation and eliminating the background.
Although the elevated temperature may partly explain the
improvements of these silver-staining methods, it has also
been reported that a lowered temperature at 5°C for initial
impregnation in 20% silver nitrate for Yamamoto–Hirano’s
modiWcation of Bielschowsky method gives more repro-
ducible results in visualizing a larger number of diVuse
plaques [73].
Molecular species detected by silver staining
It is interesting to identify isolated molecular species
detected by silver-staining methods, but these attempts
have been so far limited. Gambetti et al. used Bodian
method and anti-neuroWlament antibodies in parallel to
stain an extract from rat spinal cord electrophoresed on the
SDS-polyacrylamide gel. The typical triplet of 200, 145
and 68 kDa identiWed on the Bodian-stained gel is in agree-
ment with the neuroWlament triplet identiWed on the coun-
terpart stained with anti-neuroWlament antibodies [48].Acta Neuropathol (2007) 113:483–499 491
123
They conWrmed similar parallelism in other vertebrate and
nonvertebrate species as well [94]. Additional less intense
bands at a lower molecular weight range may correspond to
tubulin or degradation products of neuroWlament proteins
[4]. Because these Wndings have been obtained with normal
nerve tissue, further analyses based on brains containing
pathological lesions are mandatory to identify components
responsible for their argyrophilia on the pathological
lesions. Iqbal et al. [60] used Gallyas method to stain the
SDS-gel after electrophoresis of the paired helical Wlament
(PHF) fraction extracted from AD brain. The electropho-
retic mobilities of the Gallyas-positive bands correspond to
those of PHF tau (intense), normal tau (less intense) and
high molecular weight MAPs (weak). The absence of Gall-
yas-positive bands in the range of neuroWlament proteins is
in sharp contrast with the Bodian-positive triplet of neuro-
Wlament [48]. This diVerence may explain why Gallyas
method is practically free from the staining of normal struc-
tures such as neuronal soma and neurites. This discrepancy
suggests that molecular species detected by diVerent silver-
staining methods can be completely diVerent, even though
both of the methods label apparently identical structures
such as NFTs on histological sections. Because several sil-
ver-staining methods have been modiWed to stain SDS gels
[62, 78, 107], it may be possible to identify molecular spe-
cies, either normal or speciWc to some pathological struc-
tures, which have a selective aYnity to some silver-staining
methods. Because extracted proteins electrophoresed on gel
are necessarily modiWed or signiWcantly degenerated, this
approach may be fruitful only if the disease-speciWc nature,
if detectable with silver-staining methods, is readily repre-
sented by a single isolated molecule even when it is modi-
Wed for electrophoresis.
Quantitative comparison of silver-staining methods 
and immunohistochemistry
Even after the introduction of immunohistochemistry, mod-
iWcation of classic silver-staining methods or invention of
new silver-staining methods have been attempted [11, 25,
26, 98]. Two major deposits targeted by these silver-stain-
ing methods are undoubtedly NFTs and SPs of AD [31, 32,
79, 82]. DiVerent silver-staining methods [24, 27, 31, 54,
56, 67, 99, 124, 125, 127] have been compared quantita-
tively for their relative ability to detect NFTs or SPs, as rep-
resented in Fig. 2 [56]. In respect to detection of NFTs,
these comparative studies are in agreement that Gallyas
method is most powerful, followed by one of the three
methods: modiWed Bielschowsky, Bodian or Cross meth-
ods. The methenamine-silver method is rated as least
powerful for NFTs. There are two studies, each claiming a
superior or equivalent number of NFTs detected with
Reusche method [99] or with the nickel peroxidase method
[27] compared with Gallyas method. This rating of putative
sensitivity, however, is not shared when SPs are examined.
SPs are well stained by modiWed Bielschowsky [125, 131],
the methenamine-silver [1], periodic acid methenamine sil-
ver [128] or thioXavin-S [124] to similar extent. Bodian
method is less powerful in detecting SPs , especially diVuse
deposits [54, 56, 67, 127, 128]. Gallyas, Cross [56, 67] and
Garvey [27] methods are least powerful in detecting SPs.
It is needless to say that a more sensitive detection is
preferable in order to identify speciWc deposits in more
detail with ease. However, if one deals with clinicopatho-
logical correlation of a disease such as AD, where symp-
toms and deposits are more or less quantiWable under the
background of normal aging, it is possible to identify a
threshold of the deposits with any of the methods that may
correlate with a threshold of the cognitive decline [118].
For this purpose, stability and reproducibility of the method
Fig. 2 Density of NFTs (a: upper panel) and that of SPs (b: lower
panel) as a function of intellectual status evaluated by the Blessed Test
Score. Both are dependent on the staining methods. Reproduced with
permission [56]492 Acta Neuropathol (2007) 113:483–499
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are preferable [31–33,  54,  79–82]. Reliable agreement
between the conventional Braak staging of neuroWbrillary
pathology based on Gallyas method [17] and the revised
protocol based on AT8 immunohistochemistry [18] is a
good example. On the other hand, if one is looking for spe-
ciWc pathological deposits, such as Pick bodies, GCIs or
astrocytic plaques not observed in normal aging [118],
speciWcity is the primary concern for the staining method.
Some of these comparative studies included immunohisto-
chemistry for tau [31,  56, 99], A [27, 54, 56, 99, 124,
127], ubiquitin [56] or neuroWlament [24] for comparison
with silver-staining methods. Some studies with highly sen-
sitive A immunohistochemistry demonstrated that it visu-
alizes a larger number of deposits than with conventional
silver-staining methods [1, 56]. This suggests that amor-
phous A deposition, not identiWed by conventional
silver-staining methods, represents the earliest stage of A
deposition [59, 95, 129]. On the other hand, it is noteworthy
that none of the series found any quantitative superiority of
immunohistochemistry in identifying NFTs over the best-
possible silver-staining method. For example, it is rather
frequent that pathological structures in the form of NFT do
not exhibit tau-like immunoreactivity any more, while most
of them are stained by some silver-staining methods or
Xuorochromes [116]. This is explained if some tau epitopes
in NFTs are truncated out during their evolution from
pretangle to extracellular NFTs [12,  116]. Furthermore,
immunohistochemical detection is highly dependent on the
antibody and experimental procedures. These technical
uncertainties make it diYcult to place immunohistochemi-
cal detection as a standard for neuropathological diagnosis,
especially when the quantity of deposits is of primary
importance as with the histological diagnostic criteria for
AD [32, 79]. It is needless to say that the molecular speci-
Wcity of immunohistochemistry is a potentially reliable and
logical way in order to sort diVerent diseases under the
diagnostic Xags of molecules. This highly speciWc detection
by pinpointing a single target molecule is, however, “a very
restricted, monochromic view” as pointed out by Switzer
[108]”. IdentiWcation of the disease-speciWc molecular spe-
cies and their reliable probes applicable to histological sec-
tions are desirable. Even if this kind of probes are available,
immunohistochemical procedures are also diYcult to stan-
dardize and much more costly than most of silver-staining
methods [67]. Immunohistochemistry is highly costly espe-
cially when staining large histological samples, for exam-
ple, hemispheric sections of human brain. Moreover,
penetration of antibodies is sometimes not suYcient when
staining thick histological sections. Silver-staining methods
are more readily applicable even to large and thick histo-
logical sections [13]. It is of note as well that archival
materials preserved for a long period, especially in formal-
dehyde, sometimes fail to exhibit immunoreactivity. It is
frequently possible to visualize the lesions with silver-
staining methods even in these archival materials [13, 123].
Qualitative representation by silver-staining methods
As summarized in the previous section, diVerences in the
quantity of argyrophilic AD lesions are dependent on the
silver-staining method. As has been considered frequently,
it may be “the sensitivity” of a staining method that governs
the quantity of the argyrophilic lesions. This is probably in
agreement with our general impression that “modiWed
Bielschowsky method is more powerful than Bodian
method in detecting AD lesions.” [131] This interpretation
is based on the assumption that so-called “argyrophilia”
is a homogeneous phenomenon regardless of the staining
method and the nature of lesion, which is not the case. For
example, Gallyas method is one of the most “sensitive”
methods in detecting NFTs and neuropil threads in AD,
while it is far less “sensitive” in detecting SPs. This empiri-
cal but evident discrepancy is not readily explained by a
mere diVerence in the “sensitivity” of the methods and
rather indicates that argyrophilic properties are dependent
not only on the staining methods but also on the target
lesions. Careful neuropathologists have been aware of these
“method- and lesion-dependent natures” of various argyro-
philic deposits in neurodegenerative diseases [16, 85, 96].
Table 2 provides a summary of the heterogeneity of argyro-
philia according to the staining method and the lesion. Gall-
yas method is one of the most “sensitive” silver-staining
method that clearly labels NFTs of AD, as well as neuronal
and glial lesions of corticobasal degeneration/progressive
supranuclear palsy (CBD/PSP) [113, 120]. This “sensitive”
method, however, fails to stain Pick bodies, another distinct
tau-positive deposit [16, 85, 96, 117, 118]. On the other
hand, Campbell–Switzer method labels Pick bodies but not
CBD/PSP-related lesions [120,  122]. This reversed and
complementary proWle with Gallyas and Campbell–Switzer
methods is hardly explained by a superior sensitivity of
Gallyas method over Campbell–Switzer method or vise
versa. These discrepancies between Gallyas and Campbell–
Switzer methods are readily demonstrable if mirror section
pairs are initially Xuorolabeled and one of the section pair is
subsequently stained with Gallyas and the counterpart with
Campbell–Switzer method, as shown in Fig. 3. It is now
known that molecular species of tau are diVerent according
to the disease-speciWc lesions. Namely, Pick bodies are
usually composed of three-repeat (3R) tau, while CBD/
PSP-related tau pathologies are positive for four-repeat
(4R) tau [28]. Because Pick bodies are usually positive with
Campbell–Switzer method but negative with Gallyas
method (Fig. 3a–d), one of the possible interpretations is
that 3R tau deposits, such as Pick bodies, exhibit argyro-Acta Neuropathol (2007) 113:483–499 493
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philia with Campbell–Switzer but not with Gallyas method.
In contrast, the lesions of 4R tauopathy (CBD/PSP and
argyrophilic grain disease [110,  111]) are related to the
argyrophilia with Gallyas but not with Campbell–Switzer
method (Fig. 3i–l) [120]. Indeed, NFTs of AD, Down syn-
drome, and diVuse neuroWbrillary tangles with calciWcation,
all containing both 3R and 4R isoforms, similarly exhibit
argyrophilia with either method (Fig. 3e–h) [120–122]. It is
interesting that Gallyas-positive Pick-like bodies were
found to be positive for 4R tau but sparsely positive for 3R
tau [132], which corroborates the empirical correlation
between 4R tau and Gallyas method. Moreover, in one of
the largest studies on sporadic and familial frontotemporal
degeneration with tau-positive deposits, “Pick bodies” deW-
ned as “inclusions stained by Bielschowsky but not by
Gallyas” were found in 17 cases. All exhibited the immu-
noreactivity with a 3R-tau speciWc antibody as well as 3R
tau predominance in tau biochemistry except for a single
case with E342V mutation in the tau gene [29]. This partic-
ular case is characterized by diVuse cytoplasmic tau stain-
ing in neurons and PHF-like electron microscopic features
[72], both of which are not typical of Pick bodies. In
another sporadic case, Bodian-positive inclusions positive
for 4R but not 3R tau have electron microscopic features
with twisted ribbon distinct from those of typical Pick bod-
ies [83]. These apparent heterogeneities necessitate a revi-
sion of the classical deWnition of Pick bodies “round
argyrophilic, tau-positive inclusions in neuronal cyto-
plasm”, because argyrophilic features and tau-species are
both heterogeneous in this classical category. Among
argryophilic cytoplasmic inclusions in neuron, it seems that
those positive for 3R-tau [84] and those negative with Gall-
yas method [29] are correlated to form a cluster to be deW-
ned as Pick bodies. Argyrophilia with the Campbell–
Switzer method [122] is helpful for more precise and
straightforward deWnition of Pick body. In contrast with
Gallyas and Campbell–Switzer methods, argryrophilia with
Bielschowsky and Bodian methods are less dependent on
the target lesions (Table 2). It is noteworthy that tau-posi-
tive cortical lesions of PSP are silver-stained with Bodian
method [55], while those of CBD frequently fail to exhibit
argyrophilia with Bodian method [69, 109, 115] especially
in the cerebral cortices. Although possible biochemical dis-
tinctions of tau between CBD and PSP have been described
[3, 104], it remains to be clariWed how these biochemical
diVerences are related to these morphological diVerences
between CBD and PSP. Another possible limitation is
related to the observations that the expression of tau-iso-
forms is not homogeneous throughout the brain [51, 126].
Because most of the data on tau-positive deposits summa-
rized in Table 2 and Fig. 3 have been obtained on cerebral
cortices, it remains to be determined whether these Wndings
are similarly applicable to extracortical areas such as the
brainstem. Yoshida [132] demonstrated that 3R tau immu-
noreactivity is represented in the brainstem even in so-called
4R tauopathies such as CBD/PSP. Because neuroWbril-
lary pathologies related to AD or aging are sometimes
found in the brainstem nuclei and usually positive for both
3R and 4R isoforms, it remains to be clariWed whether the
presence of 3R tau in brainstem nuclei in CBD/PSP is
ascribed to tauopathies independent of normal or acceler-
ated aging.
Interestingly, argyrophilic diVerentiation with Gallyas
and Campbell–Switzer methods is not limited to tau-
Table 2 Heterogeneity of argyrophilia according to disease and method
AD Alzheimer’s disease, NFTs neuroWbrillary tangles, DNTC diVuse NFTs with calciWcation, PSP progressive supranuclear palsy, CBD cortico-
basal degeneration, SP senile plaques, GCIs glial cytoplasmic inclusions, ++: easily recognizable, +: positive, §: questionably positive, ¡: negative
a Positive in PSP cases [55] but less evident in CBD cases [67, 109, 115]
b Not consistent[97], positive in some cases, not appropriate for histological examination
c The argyrophilia (Bodian) is less evident in glia than in neurons, especially in CBD cases
Staining methods Campbell–Switzer Bodian Bielschowsky Gallyas
Pick bodies [16, 85, 96, 117, 118]+ + + + + + ¡
AD-NFTs ++ ++ ++ ++
Down-NFTs ++ ++ ++ ++
DNTC-NFTs ++ ++ ++ ++
PSP/CBD-neurons ¡ +a +b ++
PSP/CBD-glia ¡§ c +b ++
Argyrophilic grains [14, 77, 112]- + + + +
AD-SPs ++ ++ ++ +
AD-diVuse deposits ++ - § -
Lewy bodies [75, 119]+ + + + +-
GCIs [87, 90]+ + + + + +494 Acta Neuropathol (2007) 113:483–499
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Fig. 3 Silver-staining proWles of various deposits in neurodegenera-
tive diseases compared with immunoXuoresence images. (a–d Pick
bodies[122]; e–h neuroWbrillary tangles; i–l argyrophilic grains [121];
m–p glial cytoplasmic inclusions; q–t Lewy bodies [119]). Mirror sec-
tion pairs were initially multi-Xuorolabeled for PHF-tau (AT8, green
for b, c, f, g, j, k) or for -synuclein (green for n, o, r, s), with thiazin
red (red, Xuorochrome that labels Wbrillary structure such as neuroW-
brillary tangles for b, c, f, g, j, k, n, o, r, s) and for ubiquitin (blue for
f, g, j, k, n, o, r, s). After recording the Xuorescent images from the
same area of the mirror section pairs, one of the section pair was
stained with Campbell–Switzer (CS: a, e, i, m, q) and the other with
Gallyas (GAL: d, h, l, p, t) method. Fluorescent images and silver
staining proWles of the same area from the mirror section pair were
compared. Pick bodies (a–d) in the pyramidal layer of hippocampus
are stained with CS (a) but not with GAL (d) [122]. NeuroWbrillary
tangles (NFTs, e–h) from the frontal cortex of diVuse neuroWbrillary
tangles with calciWcation are stained with both CS (e) and GAL (h)
[121]. This staining proWle is shared with NFTs of AD [122]. Argyro-
philic grains (i–l, in the square) and tau-positive neurons are present (j,
k) in the parahippocampal gyrus. The tau-positive neuron (double
asterisk) and neuropil thread (arrow) stained with both CS and GAL
are similar to those observed in DNTC (e–h), representing neuroWbril-
lary pathology. Grains and pretangle neuron (single asterisk) are
stained with GAL (l) but not with CS (i) in contrast. This staining pro-
Wle is shared with cortical lesion of corticobasal degeneration/progres-
sive supranuclear palsy [120]. Glial cytoplasmic inclusions (m–p) in
the putamen, positive for -synuclein (n, o), are stained with both CS
(m) and GAL (p) [119]. Lewy bodies (arrowhead, q–t) and Lewy neu-
rites (arrow, q–t) in the dorsal motor nucleus of vagus, positive for -
synuclein (r, s), are stained with CS (q) but not with GAL (t) [119].
The same blood vessel is indicated with asterisk (q–t). Bar 50 m (a–
d,  m–p,  q–t),  bar 30 m (e–l). Reproduced with permission. a–d
[122]; e–l [121]; m–t [119]Acta Neuropathol (2007) 113:483–499 495
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positive deposits. Both of the two staining methods label
GCIs of MSA (Fig. 3m–p) [119]. Although GCIs are posi-
tive for some restricted tau epitopes [106], their major con-
stituent is now considered to be -synuclein. Indeed,
Campbell–Switzer method clearly labels Lewy bodies and
their neurites, another representative deposits of -synuc-
lein [13]. It is interesting that Gallyas method fails to label
Lewy bodies and Lewy neurites (Fig. 3q–t). Therefore,
these two silver-staining methods, when performed in par-
allel, provide staining proWles that may allow qualitative
distinction between GCIs and Lewy bodies [119]. Because
no biochemical markers that enable distinction between
Lewy bodies and GCIs are not readily available, these
diVerential proWles in silver staining provides an additional
qualitative distinction possibly linked to underlying molec-
ular diVerences.
At present, these empirical distinctions are useful for
diagnostic diVerentiation but await further explanations
preferably at molecular or ultrastructural level. These
distinctive features of silver-staining proWles may be
explained if (1) molecular species speciWc to each subcate-
gory (for example, 3R vs. 4R tau or LBs vs. GCIs) has
diVerent aYnity to each silver-staining method; (2) some
disease-speciWc ultrastructures of pathological deposit are
related to each staining proWle; (3) other independent mole-
cules in these deposits play some roles in characterizing the
pathological deposits so that distinctive silver-staining pro-
Wles are engendered; or (4) some disease-speciWc confor-
mational changes are related to a silver-staining proWle
speciWc to a disease. Because Campbell–Switzer and Gall-
yas methods are useful in discriminating not only tau-posi-
tive deposits but also -synuclein-positive deposits even
with their molecular and ultrastructural diversities, it is
plausible that factors such as (3) or (4) shared by tau-posi-
tive deposits and synuclein-positive deposits may play
roles, at least partly, in these discriminating abilities with
these silver-staining methods.
Conclusions and perspective
Even with my limited experience on these silver-staining
methods, it is apparent that the argyrophilic proWles are
dependent not only on the silver-staining method but also
on the target lesion. This indicates that “argyrophilia” is
highly heterogeneous. However, this heterogeneity is not
capricious but rather representative of some disease-spe-
ciWc aspects. The apparent empirical correlations between
the argyrophilic proWles and the disease-speciWc pathologi-
cal structures are useful in sorting these neurodegenerative
disorders. Combined silver-staining proWles, for example
with Gallyas and Campbell–Switzer methods, are more
convenient than modiWed Bielschowsky and Bodian
method for sorting diVerent disease-speciWc lesions.
Although these staining proWles are discussed in this review
as if disease-speciWc, more detailed comparison at cellular
level demonstrated that they can be diVerent from cell to
cell even in the same section (intercellular diVerences)
[117]. Furthermore, staining proWles are heterogeneous
even in a single cell (intracellular diVerences) [49]. These
silver-staining and immunohistochemical proWles are much
more informative especially when combined together than
when used in isolation because such combination is not a
mere summation of the results obtained with diVerent meth-
ods. It will rather provide a more stereoscopic and multi-
faceted view, which may allow more precise morphological
delineation of disease-speciWc deposits. In my view,
comments such as “Silver-staining methods are unreliable,
nonreproducible, nonscientiWc and out-dated.” are now
out-dated. Awareness of their utility and reliability of silver-
staining methods, diVerent from immunohistochemistry,
may facilitate diagnosis and accelerate research, which
hopefully clariWes molecular basis of each silver-staining
method and improves our understanding of diseases.
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